bibliographicCitation |
Glaser R, Glick HA, Herrmann HC, Kimmel SE. The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis. J Am Coll Cardiol. 2006 Feb 07;47(3):529–37. doi: 10.1016/j.jacc.2005.08.070. PMID: 16458131. |